Colorectal cancer (CRC) exhibits assortments of genetic irregularities involving RAS oncogenes (NRAS/KRAS/HRAS) and/or tumour suppressor genes such as APC, SMAD4, TP53, and LLGL1 [211]. This evidence concerns the gene TP53 and colorectal carcinoma.